MX386558B - Solución farmacéutica de hidrocortisona para un dispositivo de inyección. - Google Patents

Solución farmacéutica de hidrocortisona para un dispositivo de inyección.

Info

Publication number
MX386558B
MX386558B MX2019004173A MX2019004173A MX386558B MX 386558 B MX386558 B MX 386558B MX 2019004173 A MX2019004173 A MX 2019004173A MX 2019004173 A MX2019004173 A MX 2019004173A MX 386558 B MX386558 B MX 386558B
Authority
MX
Mexico
Prior art keywords
hydrocortisone
injection device
pharmaceutical solution
pharmaceutical
solution
Prior art date
Application number
MX2019004173A
Other languages
English (en)
Other versions
MX2019004173A (es
Inventor
Frédérique Flores-Ivanez
Pauline Bardonnaud
Original Assignee
Crossject
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crossject filed Critical Crossject
Publication of MX2019004173A publication Critical patent/MX2019004173A/es
Publication of MX386558B publication Critical patent/MX386558B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Se proporciona una solución farmacéutica de hidrocortisona que comprende por lo menos: hidrocortisona o una sal farmacéuticamente aceptable de la misma; rongalite; EDTA disódico; un disolvente. La invención también se relaciona con su uso en el tratamiento de insuficiencia suprarrenal aguda y asma. La invención también se relaciona con un kit de inyección que comprende un dispositivo de inyección y esta solución farmacéutica.
MX2019004173A 2016-10-26 2017-10-25 Solución farmacéutica de hidrocortisona para un dispositivo de inyección. MX386558B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1660393A FR3057775B1 (fr) 2016-10-26 2016-10-26 Solution pharmaceutique d’hydrocortisone pour dispositif d’injection
PCT/FR2017/052941 WO2018078285A1 (fr) 2016-10-26 2017-10-25 Solution pharmaceutique d'hydrocortisone pour dispositif d'injection

Publications (2)

Publication Number Publication Date
MX2019004173A MX2019004173A (es) 2019-08-26
MX386558B true MX386558B (es) 2025-03-19

Family

ID=57906786

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019004173A MX386558B (es) 2016-10-26 2017-10-25 Solución farmacéutica de hidrocortisona para un dispositivo de inyección.

Country Status (10)

Country Link
US (1) US10456355B1 (es)
EP (1) EP3532033B1 (es)
JP (1) JP6665350B2 (es)
CN (1) CN109862881A (es)
AR (1) AR110471A1 (es)
BR (1) BR112019008280A2 (es)
ES (1) ES2827551T3 (es)
FR (1) FR3057775B1 (es)
MX (1) MX386558B (es)
WO (1) WO2018078285A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3102057B1 (fr) * 2019-10-18 2021-10-29 Aguettant Lab Nouveau lyophilisat d’hémisuccinate d'hydrocortisone
KR20230104131A (ko) * 2020-09-21 2023-07-07 안타레스 팔마, 인코퍼레이티드 히드로코티손 인산나트륨 및 모노티오글리세롤의 수성 약학 제형
FR3128874B1 (fr) * 2021-11-09 2025-04-18 Crossject Solution pharmaceutique d’hydrocortisone pour dispositif d’injection
JP2025509955A (ja) * 2022-03-21 2025-04-11 アンタレス・ファーマ・インコーポレーテッド リン酸ヒドロコルチゾンナトリウム及びモノチオグリセロール水性医薬製剤
US11904046B1 (en) 2022-11-14 2024-02-20 Eton Pharmaceuticals, Inc. Hydrocortisone oral liquid formulations
WO2024214110A1 (en) * 2023-04-08 2024-10-17 Cipla Limited A safe pharmaceutical composition of hydrocortisone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4191106B2 (ja) * 1994-09-07 2008-12-03 ジョンソン・エンド・ジョンソン株式会社 レチノイド組成物
FR2807946B1 (fr) * 2000-04-19 2002-06-07 Poudres & Explosifs Ste Nale Seringue sans aiguille fonctionnant avec un chargement pyrotechnique bicomposition
FR2815544B1 (fr) 2000-10-23 2003-02-14 Poudres & Explosifs Ste Nale Seringue sans aiguille securisee a architecture compacte
GB201202433D0 (en) * 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
CN102772360B (zh) * 2012-08-22 2014-04-16 中国兽医药品监察所 一种兽用盐酸多西环素注射液及其制备方法
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
US20170128575A1 (en) * 2013-12-19 2017-05-11 Dr. Reddy' S Laboratories Ltd Liquid pharmaceutical formulations of pemetrexed
CN103816166B (zh) * 2014-02-21 2015-07-15 中国兽医药品监察所 一种兽用复方盐酸多西环素注射液及其制备方法

Also Published As

Publication number Publication date
CN109862881A (zh) 2019-06-07
EP3532033A1 (fr) 2019-09-04
EP3532033B1 (fr) 2020-08-05
US10456355B1 (en) 2019-10-29
JP6665350B2 (ja) 2020-03-13
FR3057775A1 (fr) 2018-04-27
AR110471A1 (es) 2019-04-03
FR3057775B1 (fr) 2018-11-02
ES2827551T3 (es) 2021-05-21
US20190314273A1 (en) 2019-10-17
JP2019535668A (ja) 2019-12-12
WO2018078285A1 (fr) 2018-05-03
BR112019008280A2 (pt) 2019-07-09
MX2019004173A (es) 2019-08-26

Similar Documents

Publication Publication Date Title
MX386558B (es) Solución farmacéutica de hidrocortisona para un dispositivo de inyección.
IL260852B (en) Methods, devices and systems for pulmonary delivery of active agents
ES2631504R1 (es) Medicamentos de administración nasal y métodos para su uso
CL2018000813A1 (es) Conjugados de anticuerpo-fármaco de pirrolobenzodiazepina y métodos de uso.
IL304134A (en) Compositions for treating congenital adrenal hyperplasia
IL248730B (en) Drug delivery system and method of use
EP3374900C0 (en) OPERATION OF MULTIMODAL DRUG DELIVERY SYSTEMS
LT3661514T (lt) Mavakamtenas, skirtas naudoti gydant hipertrofinę kardiomiopatiją
PL3426078T3 (pl) Wyposażenie dodatkowe skonfigurowane do ładowania urządzenia dostarczającego aerozol oraz powiązany sposób
ECSP17018120A (es) Triazolopirazinonas como inhibidores de pde1
DK3139986T3 (da) System til administration af terapeutisk gas
PL3301990T3 (pl) Sposób i przyrząd do ustanawiania powiązania
CL2017002719A1 (es) Imidazopirazinonas como inhibidores de pde1
EP3311376C0 (en) DEVICES AND METHODS FOR ADMINISTERING AND MIXING MEDICINES, AND TRAINING IN APPROPRIATE TECHNIQUES
EP3522947C0 (en) TRANSCATHETER DEVICE FOR THE DELIVERY OF INTRACORPOREAL DEVICES
CL2015002180A1 (es) Terapia de combinación para el tratamiento de neumonía nosocomial
EP3852655C0 (en) EXTENDABLE EXOSKELET DEVICES FOR DRUG ADMINISTRATION
HRP20181332T1 (hr) Derivati benzimidazola i njihovi farmaceutski pripravci, namijenjeni liječenju upalnih poremećaja
PL3281626T3 (pl) Rozpuszczalna mikroigła do dostarczania słabo rozpuszczalnego leku
IL280191A (en) Solubilized apyrases, methods and use
IL247013B (en) Stage positioning system and lithographic apparatus
GB2578712B (en) Apparatus and methods for the transdermal delivery of active agents
GT201600213A (es) Quinazolin-thf-aminas halogenadas como inhibidores de pde1
CO2017010692A2 (es) Construcciones de calicheamicina y sus métodos de uso
DK3283064T3 (da) Derivater til anvendelse i behandling af muskelatrofi